LCMS Limited received a contract to screen for b-lactam contamination in Chemical to Materials and Cell Culture Products.

LCMS Limited received multiple contracts to characterize and quantitate nut allergens in oral immune therapy formulations by trypsin digestion with LC/MS/MS for Aimmune Therapeutics . In addition LCMS Limited is performing stability studies on the formulations and developing and determining blend uniformity.

LCMS Limited together with ClorDySys received a contract for B-lactam decontaminations of a manufacturing facility and the equipment being converted for vaccine production.